The PCORnet Blood Pressure Control Laboratory: A Platform for Surveillance and Efficient Trials

Circulation. Cardiovascular Quality and Outcomes
Mark J PletcherRhonda M Cooper-DeHoff

Abstract

Uncontrolled blood pressure (BP) is a leading preventable cause of death that remains common in the US population despite the availability of effective medications. New technology and program innovation has high potential to improve BP but may be expensive and burdensome for patients, clinicians, health systems, and payers and may not produce desired results or reduce existing disparities in BP control. The PCORnet Blood Pressure Control Laboratory is a platform designed to enable national surveillance and facilitate quality improvement and comparative effectiveness research. The platform uses PCORnet, the National Patient-Centered Clinical Research Network, for engagement of health systems and collection of electronic health record data, and the Eureka Research Platform for eConsent and collection of patient-reported outcomes and mHealth data from wearable devices and smartphones. Three demonstration projects are underway: BP track will conduct national surveillance of BP control and related clinical processes by measuring theory-derived pragmatic BP control metrics using electronic health record data, with a focus on tracking disparities over time; BP MAP will conduct a cluster-randomized trial comparing effectiveness of 2 ve...Continue Reading

References

Mar 3, 2007·The New England Journal of Medicine·Bruce E LandonEdward Guadagnoli
Jun 24, 2008·The American Journal of Bioethics : AJOB·Alexander A Kon
Nov 10, 2009·Vascular Health and Risk Management·Dion ZappeUNKNOWN PROMPT Investigators
Mar 20, 2010·The Cochrane Database of Systematic Reviews·Liam G GlynnTom Fahey
Jan 25, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Manuel P MorgadoMiguel Castelo-Branco
Apr 25, 2013·Science Translational Medicine·Joseph V SelbyFrancis S Collins
Jul 4, 2013·JAMA : the Journal of the American Medical Association·Karen L MargolisNicole K Trower
Aug 31, 2013·JAMA : the Journal of the American Medical Association·Marc G JaffeAlan S Go
Sep 3, 2013·The New England Journal of Medicine·Michael S Lauer, Ralph B D'Agostino
Mar 25, 2014·American Heart Journal·Michael S Lauer, Denise Bonds
May 14, 2014·Journal of the American Medical Informatics Association : JAMIA·Rachael L FleurenceJeffrey S Brown
May 14, 2014·Journal of the American Medical Informatics Association : JAMIA·Francis S CollinsMichael S Lauer
Feb 11, 2015·Journal of the American Society of Hypertension : JASH·Nilay KumarNeetika Garg
Mar 2, 2016·Journal of Health Economics·Joseph A DiMasiRonald W Hansen
Dec 14, 2016·The New England Journal of Medicine·Rachel E ShermanRobert M Califf
Dec 16, 2016·The New England Journal of Medicine·Robert M CaliffRachel E Sherman
May 16, 2017·Current Hypertension Reports·Gianfranco ParatiDario Pellegrini
May 20, 2017·Journal of the American Medical Informatics Association : JAMIA·Dawn M Heisey-GroveJanet S Wright
Oct 4, 2017·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
Dec 31, 2017·Journal of Clinical Epidemiology·Benjamin SpeichUNKNOWN MAking Randomized Trials Affordable (MARTA) Group
Feb 23, 2018·Patient Related Outcome Measures·Mark J PletcherThomas W Carton
Mar 2, 2018·Preventing Chronic Disease·Steven M SmithRhonda M Cooper-DeHoff
Mar 13, 2018·The New England Journal of Medicine·Ronald G VictorRobert M Elashoff
Mar 5, 2019·JAMA : the Journal of the American Medical Association·Vinay K Rathi, J Michael McWilliams
Apr 18, 2019·EGEMS·Pi-I D LinUNKNOWN PCORnet Antibiotics and Childhood Growth Study Group
Jun 6, 2019·Circulation. Cardiovascular Quality and Outcomes·Brandon K BellowsValy Fontil

❮ Previous
Next ❯

Citations

Aug 28, 2020·Pharmacoepidemiology and Drug Safety·Caitrin W McDonoughWilliam R Hogan
Jul 27, 2021·JMIR Research Protocols·Alexis L BeattyGregory M Marcus
Oct 7, 2021·Journal of the American Heart Association·Rhonda M Cooper-DeHoffMark J Pletcher

❮ Previous
Next ❯

Software Mentioned

PCORnet Common Data Model
Clarity for Epic
RePORTER
Eureka
eConsent
BP
PCORnet Datamarts
PCORnet
SAS

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.